SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Beyond Meat, Inc. engages in the provision of plant-based meats. Its products include ready-to-cook meat under The Beyond Burger and Beyond Sausage brands, and frozen meat, namely, Beyond Chicken Strips and Beyond Beef Crumbles. The company was founded by Ethan Walden Brown and Brent Taylor in 2009 and is headquartered in El Segundo, CA.

Beyond Meat Inc

Beyond Meat is trending as a high-volume meme stock, with traders actively debating its potential for a short squeeze despite concerns over the company's long-term profitability and underlying product demand. Community members are closely watching for volatility and price action, using the symbol as a centerpiece for discussions on short interest, technical gap fills, and broader market sentiment regarding retail-driven trading.

Avis Budget Group, Inc. engages in the provision of vehicle sharing and rental services. It operates through the Americas and International segments. The Americas segment includes vehicle rental and car sharing operations in North America, South America, Central America, and the Caribbean. The International segment is involved in vehicle rental and car sharing operations in Europe, the Middle East, Africa, Asia, and Australasia. The company was founded in 1946 and is headquartered in Parsippany, NJ.

Avis Budget Group Inc

Avis Budget Group continues to see extreme volatility and intense debate among traders as it remains a focal point for a massive, multi-week short squeeze. The community is heavily split, with many retail participants warning of an inevitable and sharp correction while others aggressively push for further upside, fueled by concerns over a constrained float and the high cost of borrowing shares.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor Technologies is trending as investors focus on a potential breakout from its consolidation pattern, fueled by optimism surrounding the company's vertically integrated housing transaction stack and upcoming earnings. The community is actively discussing a mix of technical indicators, high short interest, and the perceived long-term value of the company's AI-driven mortgage and title products.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is seeing a wave of positive sentiment as investors cheer strong quarterly earnings, upwardly revised profit guidance, and a newly announced share buyback program. The community is actively discussing the stock's renewed momentum, debating the potential for a short squeeze, and highlighting the company's defensive value proposition as a catalyst for a long-term turnaround.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas Semiconductor is trending as the community debates its long-term potential in AI data center power efficiency versus skepticism over its current valuation and lack of major design win announcements. Traders are actively analyzing recent institutional activity and management changes while hedging against volatility with significant option activity leading up to upcoming earnings.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is experiencing significant market attention as traders bet on a potential short squeeze, driven by elevated short interest and anticipation surrounding upcoming earnings. The stock's recent volatility and high trading volume have sparked intense community debate, with bulls focusing on enterprise contract growth and long-term agentic AI integration, while skeptics warn of ongoing cash burn and dilution risks.

SEALSQ Corp. is a holding company, which engages in the security of microcontrollers. It operates through the following geographical segments: North America, Europe, Middle East, Africa, Asia Pacific, and Latin America. It focuses on authentication process, digital certification, and covering individual patents of semiconductors. The company was founded on April 1, 2022 and is headquartered in Cointrin, Switzerland.

SEALSQ Corp

SEALSQ Corp is seeing increased investor focus due to its role in the emerging post-quantum cybersecurity sector, bolstered by significant collaborations and a shift toward government-grade, quantum-resistant hardware. While the community is actively debating the company's valuation, cash position, and the impact of dilutive financing, many are highlighting the strategic importance of their hardware-focused approach in an era of rapidly advancing quantum threats.

Clover Health Investments Corp. is a physician enablement technology company, which engages in the provision of Medicare Advantage plans in the United States. Its strategy is powered by its proprietary software platform, Clover Assistant, which aggregates patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic diseases. The company offers PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on its flagship wide-network, high-choice PPO plans. The company was founded by Vivek Garipalli and Andrew Toy on July 17, 2014 and is headquartered in Wilmington, DE.

Clover Health Investments Corp - Ordinary Shares - Class A

Clover Health Investments Corp

Clover Health is currently drawing attention from investors as it navigates a critical transition, highlighted by the departure of its CFO and active legal challenges regarding CMS star ratings. The community is actively debating the potential for long-term profitability and SaaS-driven growth, while monitoring for strategic shifts as the company prepares for upcoming earnings.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull is seeing significant retail interest and a bullish sentiment surge following the announcement of a 100 million dollar share repurchase program. Investors are actively discussing the stock's potential for a short squeeze and long-term recovery, while highlighting recent structural catalysts like the termination of dilutive equity facilities and upcoming regulatory shifts favoring active trading.

Velo3D, Inc. operates as a technology company, which engages in developing and manufacturing metal laser sintering printing machines for 3D printing. Its products include assure system, flow software, sapphire printer & sapphire XC. The company was founded by Benyamin Buller in June 2014 and is headquartered in Fremont, CA.

Velo3D Inc

Velo3D is experiencing high momentum driven by significant insider confidence, as top executives recently converted corporate debt into equity at a premium to the current share price. The community is buzzing over these signals of long-term belief in the company's manufacturing technology for aerospace and defense, while keeping a close eye on potential contract wins and the upcoming earnings report.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>LCID slid for a third straight day after TD Cowen and Baird trimmed their price targets following recent company updates and capital raises.</li><li>ABT dropped after cutting its 2026 EPS outlook to $5.38-$5.58 due to the impact of its $23 billion acquisition of Exact Sciences.</li><li>ASBP slumped after shareholders approved a reverse stock split and authorized additional equity issuance tied to preferred-stock conversion and financing deals.</li></ul>Shares of Lucid Group (LCID), Abbott Laboratories (ABT) and Aspire Biopharma Holdings (ASBP) dropped to fresh 52-week lows Thursday, bucking a broader market rally, as investors weighed softer growth prospects and dilution risks across the three companies.On Thursday,&nbsp;<a href="https://stocktwits.com/symbol/LCID">LCID</a> and&nbsp;<a href="https://stocktwits.com/symbol/ABT">ABT</a> shares each fell about 6%, while&nbsp;<a href="https://stocktwits.com/symbol/ASBP">ASBP</a> slumped 45%.<h2 class="st-heading-2">LCID Falls As Outlook Confidence Wavers</h2>LCID shares fell 6% on Thursday, extending their decline to a third straight session, after multiple Wall Street firms lowered price targets following recent company updates in a weaker auto market.&nbsp;Earlier this week, TD Cowen analyst Itay Michaeli cut the firm’s price target to $10 from $19 and maintained a ‘Hold’ rating, saying automakers appear better positioned than suppliers in the first quarter (Q1) to provide investors with outlook “reassurances and retaining guidance credibility.” The brokerage added that guide-down risk across the sector remains low.Baird also lowered its price target to $12 from $14 and kept a ‘Neutral’ rating after updating its model following the appointment of a permanent CEO and expansion of Lucid’s partnership with Uber.Investor sentiment has also remained under pressure from a recent $1.05 billion capital raise and a $300 million stock offering. The company is targeting production of 25,000 to 27,000 vehicles in 2026, but produced 5,500 vehicles and delivered 3,093 units in Q1 after deliveries were temporarily affected by a Gravity SUV seat-belt recall.<h2 class="st-heading-2">ABT Slides On Exact Sciences Impact To Bottomline</h2>ABT shares posted their worst session in nearly three months on Thursday after the company lowered its 2026 adjusted profit outlook due to the impact of its $23 billion acquisition of Exact Sciences.Abbott cut its full-year outlook and now expects adjusted earnings per share of $5.38 to $5.58, down from its earlier forecast of $5.55 to $5.8. Investors focused on softer organic growth trends, weakness in the nutrition segment and slower-than-expected momentum in diabetes and structural-heart devices, facing competition from Edwards Lifesciences.Evercore ISI lowered its price target to $120 from $134, saying organic growth came in “a tad below” expectations and base organic guidance was effectively reduced by about 50 basis points.However, Abbott said that the $23 billion acquisition of Exact Sciences is expected to contribute about $3 billion in incremental sales this year and support longer-term growth as Abbott continues to shift away from declining COVID testing revenue.<h2 class="st-heading-2">ASBP Slumps On Dilution Concerns</h2>ASBP shares remained under pressure after stockholders approved several proposals expanding the company’s flexibility to issue additional equity and restructure its capital base.At a special meeting earlier this month, investors approved a reverse stock split within a range of 1-for-5 to 1-for-500 and authorized the issuance of conversion shares tied to Series A preferred stock. Stockholders also approved additional equity issuance under an existing purchase agreement with Arena Business Solutions Global SPC II. A proposal to increase the authorized common shares from 490 million to 700 million was also approved.The company separately completed a preferred-stock financing tranche, generating about $10 million in proceeds, while converting part of its outstanding debt into equity, underscoring investor concerns around dilution risk and huge funding needs.Additionally, Aspire entered a letter of intent to acquire Dura Driver Control Systems in a $30 million deal to expand its footprint beyond drug delivery.<h2 class="st-heading-2">How Do Retail Traders Feel About LCID, ABT, ASBP?</h2>On Stocktwits, retail sentiment for LCID and ABT was ‘extremely bullish’ amid ‘extremely high’ message volume, while sentiment for ASBP was ‘bullish’ with ‘extremely high’ message volume.Over the past year, LCID shares have declined 67%, ABT is down 25%, and ASBP has plunged 99%.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/nio-stock-outpaces-2025-gains-battery-swap-rollout-focus/cZJUf82RIx7">Nio Stock Already Outruns Last Year’s Gains — Now A Massive Battery-Swap Push Is Coming Into Spotlight</a>

In this photo illustration, the logo of Lucid Group, Inc. is displayed on a smartphone screen, with a stock market chart in the background, on May 4, 2025, in Chongqing, China. (Photo illustration by Cheng Xin/Getty Images)

LCID, ABT, ASBP Stocks Hit 52-Week Lows Today: What’s Driving The Selloff?

LCID and ABT each fell about 6% on Thursday, while ASBP plunged 45%, bucking a broader market rally.

Equity

Wealth Enhancement Advisory Services LLC Buys 18,415 Shares of Exact Sciences Corporation $EXAS

Wealth Enhancement Advisory Services LLC increased its stake in Exact Sciences Corporation (NASDAQ:EXAS - Free Report) by 24.7% in the fourth quarter, according to the company in its most recent...

Syquant Capital Sas Acquires Shares of 92,010 Exact Sciences Corporation $EXAS

Syquant Capital Sas bought a new position in shares of Exact Sciences Corporation (NASDAQ:EXAS - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 92,010 shares of the medica...

Promising Medical Stocks To Follow Now - March 24th

Exact Sciences, Eli Lilly and Company, UnitedHealth Group, Johnson & Johnson, and ImmunityBio are the five Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks...

Exact Sciences' (EXAS) "Neutral" Rating Reaffirmed at BTIG Research

BTIG Research restated a "neutral" rating on shares of Exact Sciences in a research report on Tuesday...

Exact Sciences (NASDAQ:EXAS) Sets New 12-Month High  - Time to Buy?

Exact Sciences (NASDAQ:EXAS) Hits New 12-Month High - What's Next...

Medical Stocks To Research - March 23rd

Exact Sciences, UnitedHealth Group, and Eli Lilly and Company are the three Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks are shares of publicly traded companies whose primary business is the development, manufacture, distribution, or provision of heal...

Marshall Financial Group LLC Purchases Shares of 17,663 Exact Sciences Corporation $EXAS

Marshall Financial Group LLC acquired a new stake in shares of Exact Sciences Corporation (NASDAQ:EXAS - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 17,663 shares of t...

Promising Medical Stocks To Research - March 20th

UnitedHealth Group, Eli Lilly and Company, Johnson & Johnson, Exact Sciences, Merck & Co., Inc., AbbVie, and Amgen are the seven Medical stocks to watch today, according to MarketBeat's stock...

Exact Sciences (NASDAQ:EXAS) Sees Unusually-High Trading Volume  - Time to Buy?

Exact Sciences (NASDAQ:EXAS) Sees Large Volume Increase - Time to Buy...

EXACT Sciences Corp. is a cancer screening and diagnostics company. The firm focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. The company was founded on February 10, 1995, and is headquartered in Madison, WI.

EXAS
Exact Sciences Corp.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest EXAS News

EXASExact Sciences Corp.